Altria's stock nears 52-week high despite regulatory and dividend concerns
Altria's stock has climbed over 18% since early 2024, now trading near its 52-week high of 57.84 EUR. The tobacco giant, valued at 112.42 billion EUR, faces both investor optimism and growing regulatory challenges across Europe.
With a quarterly dividend of $1.06 per share—yielding about 6.5%—the company is preparing for its next payout on April 30, though its high payout ratio has drawn attention.
In its latest quarterly report, Altria posted earnings per share of $1.30, just below analyst expectations. Revenue also slipped by 0.5% year-over-year, highlighting ongoing operational pressures. Despite this, the company's strong 2024 net profit exceeded 11 billion USD, supported by a focus on oral nicotine alternatives following its exit from NJOY and a leadership transition.
UBS recently raised its price target for Altria to 74 USD, keeping a buy rating. The firm cited stabilising cigarette volume declines and robust Q4 2025 revenue of 5.08 billion USD as key positives. Yet, the stock's relative strength index (RSI) of 76.9 suggests it may be slightly overbought after its recent rally. Regulatory hurdles are mounting, particularly in Europe. Spain is debating stricter limits on nicotine pouches, while Belgium grapples with a surge in illicit tobacco trade. These challenges add to investor concerns, even as Altria's generous dividend yield provides some financial cushion. Major asset managers are adjusting their positions ahead of the March 25 ex-dividend date. Stillwater Wealth Management Group has opened a new $1.52 million stake in the company. Meanwhile, Mainstay Capital Management, Wilmington Savings Fund Society, and Swiss Life Asset Management have all reduced their holdings, reflecting mixed confidence in Altria's near-term outlook.
The upcoming dividend payout on April 30 remains a focal point for shareholders. While Altria's strong financials and dividend yield offer support, its high payout ratio and regulatory pressures in Europe present ongoing risks. Investors will be watching how the company balances growth with these challenges in the months ahead.
